ProfileGDS4132 / 230519_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 34% 36% 37% 42% 33% 33% 40% 32% 34% 42% 34% 39% 32% 32% 40% 36% 28% 35% 37% 40% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10185.004334
GSM201543Muscle PCOS pioglitazone 12182.958236
GSM201544Muscle PCOS pioglitazone 16197.817637
GSM201545Muscle PCOS pioglitazone 201116.39742
GSM201829Muscle PCOS pioglitazone 23187.368233
GSM201830Muscle PCOS pioglitazon 25184.005733
GSM201831Muscle PCOS pioglitazone 271103.91340
GSM201832Muscle PCOS pioglitazone 3180.871832
GSM201833Muscle PCOS pioglitazone 4181.536834
GSM201834Muscle PCOS pioglitazone 81108.16442
GSM201835Muscle PCOS after pioglitazone 10271.251834
GSM201836Muscle PCOS after pioglitazone 12289.304239
GSM201837Muscle PCOS after pioglitazone 16266.399332
GSM201838Muscle PCOS after pioglitazone 20269.3932
GSM201839Muscle PCOS after pioglitazone 23294.827940
GSM201840Muscle PCOS after pioglitazone 25288.407936
GSM201841Muscle PCOS after pioglitazone 27253.189728
GSM201842Muscle PCOS after pioglitazone 3270.653335
GSM201843Muscle PCOS after pioglitazone 4290.360337
GSM201844Muscle PCOS after pioglitazone 8297.240140